title: [Effectiveness of strattera in children and adolescents with attention deficit hyperactivity disorder].
abstract: A group of children and adolescents with ADHD (25 boys and 9 girls), aged 6-17 years, were treated with strattera in the optimum dose (1,2 mg/day) on an outpatient basis. The assessment of treatment effectiveness showed the marked and moderately pronounced clinical effect in 78,1% patients after 3 months. The psychological study revealed a positive trend in the volume and speed of switching attention in 80% of children and the improvement of sustainability of attention - in 69%. Control EEG revealed the decrease in the <<index of deceleration>> in 70,2% of patients. Safety and good tolerance of strattera in the treatment of children and adolescents with ADHD were confirmed.
authors.forename: I N
authors.initials: IN
authors.lastname: Vakula
authors.forename: Iu Sh
authors.initials: IuSh
authors.lastname: Vasianina
authors.forename: Z Kh
authors.initials: ZKh
authors.lastname: Gorbunova
authors.forename: E Iu
authors.initials: EIu
authors.lastname: Nikiforova
authors.forename: E I
authors.initials: EI
authors.lastname: Ponomarenko
mesh_terms: D000293:Adolescent; D018759:Adrenergic Uptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000069445:Atomoxetine Hydrochloride; D001288:Attention / Q000187:drug effects* / Q000502:physiology; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D002648:Child; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D010045:Outpatients; D011437:Propylamines / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D018759:Adrenergic Uptake Inhibitors; D011437:Propylamines; D000069445:Atomoxetine Hydrochloride